Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04645134 · ClinicalTrials.gov registry record
Physical Activity and Cognitive Function in Older Adults: A Novel Role for GPLD1
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 25
- Enrollment target
NCT04645134: Completed study, sponsored by Pennington Biomedical Research Center.
NCT04645134 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04645134 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The investigators are conducting a cross-sectional, observational study to investigate whether plasma GPLD1 concentrations are associated with higher cognitive function and better brain structure and function in two groups of older adults with high or low levels of physical activity.
Primary Outcome
Plasma GPLD1 (by a blood draw) is performed.
Interventions
- BEHAVIORAL Brain Health Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2022-03-17 |
What the finished NCT04645134 record still lists
NCT04645134 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Brain Health Assessments is the first listed.
NCT04645134 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04645134 about?
NCT04645134 is a clinical study titled "Physical Activity and Cognitive Function in Older Adults: A Novel Role for GPLD1". The investigators are conducting a cross-sectional, observational study to investigate whether plasma GPLD1 concentrations are associated with higher cognitive function and better brain structure and function in two groups of older adults with high or low levels of physical activity.
What is the current status of trial NCT04645134?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2021-04-01. Estimated completion is 2022-03-17.
What interventions are being tested in trial NCT04645134?
The interventions under investigation include: Brain Health Assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT04645134?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI